2025
Bioprostheses and Mechanical Prostheses for Aortic Valve Replacement in Patients Aged 50 to 65 Years Offer Similar Long-Term Survival Rates
TOPORCER, Tomas; Stefan LUKACIN; Andrea KRAUS; Marian HOMOLA; Anton BERES et al.Základní údaje
Originální název
Bioprostheses and Mechanical Prostheses for Aortic Valve Replacement in Patients Aged 50 to 65 Years Offer Similar Long-Term Survival Rates
Autoři
TOPORCER, Tomas; Stefan LUKACIN; Andrea KRAUS; Marian HOMOLA; Anton BERES; Michal TREBISOVSKY; Denis RADOTZY; Vilem ROHN a Adrian KOLESAR
Vydání
Journal of Cardiovascular Development and Disease, Basel, MDPI, 2025, 2308-3425
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30201 Cardiac and Cardiovascular systems
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.300 v roce 2024
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14310/25:00140825
Organizační jednotka
Přírodovědecká fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
aortic valve replacement; aortic valve stenosis; mechanical prosthesis; bioprosthesis
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 12. 3. 2025 16:16, Mgr. Marie Novosadová Šípková, DiS.
Anotace
V originále
Background: Aortic valve replacement (AVR) is the definitive therapy for patients with severe aortic valve stenosis (AoS). The aim of this work is to compare the effect of a mechanical prosthesis (MP) and a bioprosthesis (BP) on the survival of patients aged 50–65 years after AVR. Methods: The retrospective analysis included 276 patients aged 50 to 65 years who had undergone isolated AVR for AoS; 161 patients were implanted with an MP and 115 with a BP. Patient survival, adjusted for age, gender and risk parameters affecting survival, was assessed. A subgroup analysis was performed on the 208 patients with a modern valve (prosthesis models that are no longer used in clinical practice were removed from the sample). Results: After adjusting for risk factors for overall survival as well as for age and sex, the implantation of an MP did not have a significant effect on overall survival in comparison to a BP, at a median follow-up of 10.3 years (p = 0.477). The size of the MP had no significant effect on overall survival either (HR: 1.29; 95%CI: 0.16–10.21; p = 0.812). However, the indexed effective orifice area of the BP had a positive effect on overall survival (HR: 0.09; 95%CI: 0.01–0.78; p = 0.029). Conclusions: The estimated survival of patients aged between 50 and 65 years after implantation of a BP with a sufficiently large indexed effective orifice area may exceed that of patients with an MP.